COVID-19 Vaccine Registration

COVID-19  Vaccination Clinics  – Vaccine supply is limited.

Genesee County – Please call (585) 344-2580 ext. 5555 to check vaccine availability and to make an appointment.  Genesee clinics will be held on the 1st & 3rd Wednesday of the month.  Use the above number for appointments at the Genesee County Health Department.

Orleans County– Please call (585) 589-3278 to check vaccine availability and to make an appointment.  Orleans clinics will be held on the 2nd & 4th Thursday of the month.  Use the above number for appointments at the Orleans County Health Department.

The Moderna Bivalent COVID-19 Vaccine is now authorized for the following:

Individuals 6 months through 5 years of age:

  • Unvaccinated individuals:  Two doses of Moderna COVID-19 Vaccine, Bivalent is administered. The second dose is administered 1 month after the first.
  • Individuals who have received one dose of Moderna COVID-19 Vaccine: A single dose of Moderna COVID-19 Vaccine, Bivalent is administered 1 month after the dose of Moderna COVID-19 Vaccine.
  • Individuals who have received two doses of Moderna COVID-19 Vaccine: A single dose of Moderna COVID-19 Vaccine, Bivalent is administered at least 2 months after the last dose of Moderna COVID-19 Vaccine.

Individuals 6 years of age and older:

  • Unvaccinated individuals: A single dose of Moderna COVID-19 Vaccine, Bivalent.
  • Individuals who have received one or more doses of a monovalent COVID-19 vaccine: A single dose of Moderna COVID-19 Vaccine, Bivalent is administered at least 2 months after any monovalent COVID-19 vaccine.
  • Individuals 65 years of age and older who have received one dose of a bivalent COVID-19 vaccine:  A dose of Moderna COVID-19 Vaccine, Bivalent may be administered at least 4 months after the dose of the bivalent COVID-19 vaccine.         

Immunocompromised individuals 6 months of age and older:

  • For immunocompromised individuals 6 months through 5 years of age who have received two doses (Moderna COVID-19 Vaccine or Moderna COVID-19 Vaccine, Bivalent), a single additional dose of Moderna COVID-19 Vaccine, Bivalent may be administered at least 1 month following the most recent dose of Moderna COVID-19 Vaccine, Bivalent; additional doses of Moderna COVID-19 Vaccine, Bivalent may be administered at the discretion of the healthcare provider, taking into consideration the individual’s clinical circumstances.
  • For immunocompromised individuals 6 years of age and older, a single additional age-appropriate dose of Moderna COVID-19 Vaccine, Bivalent may be administered at least 2 months following the initial dose of a bivalent COVID-19 vaccine; additional age-appropriate doses of Moderna COVID-19 Vaccine, Bivalent may be administered at the discretion of the healthcare provider, taking into consideration the individual’s clinical circumstances.                                                

The Pfizer Bivalent COVID-19 Vaccine is now authorized for the following:

Individuals 6 months through 4 years of age:

  • Unvaccinated individuals: Three doses of Pfizer-BioNTech COVID-19 Vaccine, Bivalent are administered over at least 11 weeks. The first two doses are administered three weeks apart. The third dose is administered at least 8 weeks after the second dose.
  • Individuals who have received one dose of the monovalent Pfizer BioNTech COVID-19 Vaccine: Two doses of Pfizer-BioNTech COVID-19 Vaccine, Bivalent are administered. The first dose of Pfizer-BioNTech COVID-19 Vaccine, Bivalent is given three weeks after the monovalent Pfizer-BioNTech COVID-19 Vaccine, and the second dose at least 8 weeks later.
  • Individuals who have received two doses of the monovalent Pfizer BioNTech COVID-19 Vaccine: A single dose of Pfizer-BioNTech COVID-19 Vaccine, Bivalent is administered at least 8 weeks after the monovalent Pfizer-BioNTech COVID-19 Vaccine.
  • Individuals who have received three doses of the monovalent Pfizer BioNTech COVID-19 Vaccine: A single dose of Pfizer-BioNTech COVID-19 Vaccine, Bivalent is administered at least 2 months after the monovalent Pfizer BioNTech COVID-19 Vaccine.

Individuals 5 years of age and older:

  • Unvaccinated individuals: A single dose of Pfizer-BioNTech COVID-19 Vaccine, Bivalent. 
  • Individuals who have received one or more doses of a monovalent COVID-19 vaccine: A single dose of Pfizer-BioNTech COVID-19 Vaccine, Bivalent is administered at least 2 months after any monovalent COVID-19 vaccine. 
  • Individuals 65 years of age and older who have received one dose of a bivalent COVID-19 vaccine: A dose of Pfizer-BioNTech COVID-19 Vaccine, Bivalent may be administered at least 4 months after the dose of the bivalent COVID-19 vaccine.
  • Immunocompromised individuals 5 years of age and older who have received one dose of a bivalent COVID-19 vaccine: An additional dose with Pfizer-BioNTech COVID-19 Vaccine, Bivalent may be administered at least 2 months following the dose of the bivalent COVID-19 vaccine; additional doses may be administered at the discretion of the healthcare provider.

 

Source: U.S. Food and Drug Administration 

Stay up to Date with COVID-19 Vaccines Including Boosters, click here

COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised, click here

For other vaccine providers, including pharmacies, click here.

For more information about COVID-19 vaccines visit the NYS Vaccination webpage, click here 

Comments are closed.

Close Search Window
Translate »